Oramed Pharmaceuticals Inc. (ORMP) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 68.15M | 133.27M | 136.12M | 99.03M | 131.48M | 143.22M | 142.77M | 153.27M | 177.09M | 162.58M | 175.71M | 150.97M |
| Cash & Short-Term Investments | 65.84M | 125.89M | 134.69M | 97.94M | 130.64M | 141.93M | 142.3M | 152.74M | 176.59M | 162.05M | 175.04M | 150.2M |
| Cash Only | 13.2M | 45.95M | 52.18M | 15.8M | 74.52M | 54.42M | 42.1M | 84.75M | 18.58M | 9.05M | 5.47M | 6.77M |
| Short-Term Investments | 52.64M | 79.95M | 82.51M | 82.14M | 56.13M | 87.51M | 100.2M | 67.98M | 158.02M | 152.99M | 169.57M | 143.43M |
| Accounts Receivable | 0 | 4.64M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 2.31M | 2.74M | 1.43M | 1.09M | 832K | 1.29M | 0 | 533K | 501K | 537K | 666K | 769K |
| Total Non-Current Assets | 200.7M | 97.59M | 84.38M | 62.66M | 16.06M | 12.06M | 22.31M | 30.95M | 26.56M | 57.97M | 55.19M | 5.34M |
| Property, Plant & Equipment | 1.25M | 1.34M | 1.43M | 3.48M | 2.23M | 1.11M | 1.2M | 1.33M | 1.43M | 1.57M | 1.69M | 1.79M |
| Fixed Asset Turnover | - | - | - | - | 1.20x | - | - | - | - | - | - | 0.37x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 199.4M | 93.74M | 82.9M | 56.61M | 9.53M | 10.91M | 21.07M | 29.59M | 25.09M | 56.37M | 53.47M | 3.52M |
| Other Non-Current Assets | 48K | 2.52M | 42K | 2.57M | 4.3M | 34K | 32K | 30K | 36K | 34K | -55.16M | 33K |
| Total Assets | 268.85M | 230.86M | 220.49M | 161.68M | 147.54M | 155.28M | 165.08M | 184.22M | 203.65M | 220.55M | 230.89M | 156.31M |
| Asset Turnover | - | - | - | - | 0.01x | - | - | - | - | - | - | 0.00x |
| Asset Growth % | 82.22% | 48.68% | 33.57% | -12.23% | -27.55% | -29.6% | -28.5% | 17.85% | 27.46% | 36.44% | 40.41% | -3.68% |
| Total Current Liabilities | 10.56M | 19.09M | 6.12M | 3.69M | 5.49M | 5.68M | 5.27M | 3.73M | 33.56M | 53.21M | 78.17M | 1.07M |
| Accounts Payable | 481K | 443K | 560K | 715K | 509K | 789K | 5M | 3.48M | 1.27M | 551K | 2.56M | 828K |
| Days Payables Outstanding | - | - | 1.89K | - | 29.4 | 8.58K | - | - | - | - | - | - |
| Short-Term Debt | 268K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32.03M | 51.01M | 75.61M | 236K |
| Deferred Revenue (Current) | 1.47M | 1.35M | 986K | 1.24M | 0 | 0 | 0 | 0 | 0 | 0 | 4M | 4M |
| Other Current Liabilities | 3.23M | 0 | 0 | 0 | 0 | 0 | 35K | 0 | 1K | 325K | -6.56M | -4.83M |
| Current Ratio | 6.45x | 6.98x | 22.24x | 26.81x | 23.94x | 25.19x | 27.08x | 41.06x | 5.28x | 3.06x | 2.25x | 141.49x |
| Quick Ratio | 6.45x | 6.98x | 22.24x | 26.81x | 23.94x | 25.19x | 27.08x | 41.06x | 5.28x | 3.06x | 2.25x | 141.49x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 20.01M | 12.03M | 12.04M | 4.41M | 2.15M | 4.25M | 4.29M | 4.34M | 4.38M | 4.44M | 4.49M | 4.59M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 389K | 488K |
| Capital Lease Obligations | 493K | 540K | 589K | 648K | 120K | 156K | 186K | 236K | 272K | 342K | 0 | 0 |
| Deferred Tax Liabilities | 17.75M | 7.91M | 7.92M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11K | 11K |
| Other Non-Current Liabilities | 238K | 314K | 38K | 36K | 33K | 90K | 4.1M | 100K | 103K | 102K | 88K | 93K |
| Total Liabilities | 30.57M | 31.12M | 18.16M | 8.1M | 7.64M | 9.93M | 9.56M | 8.07M | 37.93M | 57.66M | 82.66M | 5.66M |
| Total Debt | 761K | 825K | 860K | 912K | 301K | 372K | 429K | 486K | 32.56M | 51.62M | 76M | 724K |
| Net Debt | -12.44M | -45.12M | -51.32M | -14.88M | -74.22M | -54.05M | -41.67M | -84.27M | 13.98M | 42.57M | 70.53M | -6.04M |
| Debt / Equity | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.20x | 0.32x | 0.51x | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | -1.76x | -0.63x | -0.20x | 42.52x | 3.59x | 11.98x | -3.50x | - |
| Total Equity | 238.28M | 199.74M | 202.33M | 153.58M | 139.89M | 145.35M | 155.52M | 176.15M | 165.72M | 162.89M | 148.23M | 150.66M |
| Equity Growth % | 70.33% | 37.43% | 30.1% | -12.81% | -15.58% | -10.77% | 4.92% | 16.93% | 10.37% | 7.76% | -3.21% | -1.56% |
| Book Value per Share | 5.68 | 4.71 | 4.73 | 3.60 | 3.39 | 3.64 | 3.80 | 4.24 | 3.99 | 4.02 | 3.66 | 3.75 |
| Total Shareholders' Equity | 238.28M | 199.74M | 203.28M | 154.53M | 140.81M | 146.26M | 156.44M | 177.06M | 166.64M | 163.82M | 149.13M | 151.55M |
| Common Stock | 491K | 472K | 490K | 491K | 491K | 480K | 484K | 488K | 487K | 485K | 484K | 484K |
| Retained Earnings | -85.12M | -123.44M | -122.58M | -170.97M | -184.26M | -176.62M | -166.43M | -146.81M | -156.02M | -157.56M | -170.89M | -167.67M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | -952K | -946K | -918K | -918K | -919K | -911K | -918K | -928K | -902K | -891K |